UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice

Hepatology (Baltimore, Md.), 2012-07, Vol.56 (1), p.270-280

2012

Volltextzugriff (PDF)

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

Nature reviews. Gastroenterology & hepatology, 2022-07, Vol.19 (7), p.432-450

2022

Volltextzugriff (PDF)

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

Journal of hepatology, 2016-03, Vol.64 (3), p.674-681

2016

Volltextzugriff (PDF)

Metabolic Preconditioning Protects BSEP/ABCB11-/- Mice against Cholestatic Liver Injury

Journal of hepatology, 2017-01, Vol.66 (1), p.95-101

2017

Volltextzugriff (PDF)

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption[S]

Journal of lipid research, 2019-07, Vol.60 (7), p.1284-1292

2019

Volltextzugriff (PDF)

24- nor -ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

Journal of hepatology, 2015-04, Vol.62 (4), p.871-878

2015

Volltextzugriff (PDF)

Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice

International journal of molecular sciences, 2021-02, Vol.22 (4), p.2126

2021

Volltextzugriff (PDF)

Bile acid metabolism and signaling in liver disease

Journal of hepatology, 2024-09

2024

Volltextzugriff (PDF)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis

JHEP reports, 2023-11, Vol.5 (11), p.100874-100874, Article 100874

2023

Volltextzugriff (PDF)

Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease

Seminars in liver disease, 2016-02, Vol.36 (1), p.69-86

2016

Volltextzugriff (PDF)

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Nature (London), 2023-03, Vol.615 (7950), p.134-142

2023

Volltextzugriff (PDF)

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects

Hepatology communications, 2022-09, Vol.6 (9), p.2368-2378

2022

Volltextzugriff (PDF)

Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD

Trends in endocrinology and metabolism, 2014-11, Vol.25 (11), p.576-585

2014

Volltextzugriff (PDF)

Bile acids in regulation of inflammation and immunity: friend or foe?

Clinical and experimental rheumatology, 2016-07, Vol.34 (4 Suppl 98), p.25

2016

Volltextzugriff (PDF)

FXR controls CHOP expression in steatohepatitis

FEBS letters, 2017-10, Vol.591 (20), p.3360-3368

2017

Volltextzugriff (PDF)

Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice

Hepatology (Baltimore, Md.), 2022-01, Vol.75 (1), p.125-139

2022

Volltextzugriff (PDF)

Bsep/Abcb11 knockout ameliorates Schistosoma mansoni liver pathology by reducing parasite fecundity

Liver international, 2023-11, Vol.43 (11), p.2469-2478

2023

Volltextzugriff (PDF)

Loss of bile salt export pump aggravates lipopolysaccharide‐induced liver injury in mice due to impaired hepatic endotoxin clearance

Hepatology (Baltimore, Md.), 2022-05, Vol.75 (5), p.1095-1109

2022

Volltextzugriff (PDF)

Liver Capsule: FXR agonists against liver disease

Hepatology (Baltimore, Md.), 2016-11, Vol.64 (5), p.1773-1773

2016

Volltextzugriff (PDF)

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis

Hepatology (Baltimore, Md.), 2020-05, Vol.71 (5), p.1750-1765

2020

Volltextzugriff (PDF)

Na+‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice

Hepatology (Baltimore, Md.), 2018-09, Vol.68 (3), p.1057-1069

2018

Volltextzugriff (PDF)

Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice

Liver international, 2020-06, Vol.40 (6), p.1366-1377

2020

Volltextzugriff (PDF)

Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice

Hepatology (Baltimore, Md.), 2012-07, Vol.56 (1), p.270-280

2012

Volltextzugriff (PDF)

GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2-/- Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR Signaling

Cellular and molecular gastroenterology and hepatology, 2023-01, Vol.16 (5), p.847-856

2023

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

Metabolic Preconditioning Protects BSEP/ABCB11-/- Mice against Cholestatic Liver Injury

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption[S]

24- nor -ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis

Absence of Adiponutrin (PNPLA3) and Monoacylglycerol Lipase Synergistically Increases Weight Gain and Aggravates Steatohepatitis in Mice

Bile acid metabolism and signaling in liver disease

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis

Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects

Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD

Bile acids in regulation of inflammation and immunity: friend or foe?

FXR controls CHOP expression in steatohepatitis

Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice

Bsep/Abcb11 knockout ameliorates Schistosoma mansoni liver pathology by reducing parasite fecundity

Loss of bile salt export pump aggravates lipopolysaccharide‐induced liver injury in mice due to impaired hepatic endotoxin clearance

24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation

Liver Capsule: FXR agonists against liver disease

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis

Na+‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice

Absence of Bsep/Abcb11 attenuates MCD diet‐induced hepatic steatosis but aggravates inflammation in mice

Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice

GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2-/- Mice Via Activation of NR4a1/Nur77 in Hepatic Stellate Cells and Intestinal FXR Signaling

Suchergebnisse filtern